| [21] |
Ladanyi A，Mukherjee A，Kenny HA，et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis［J］. Oncogene，2018，37（17）：2285-2301.
|
| [22] |
Watt MJ，Clark AK，Selth LA，et al. Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer［J］. Sci Transl Med，2019，11（478）：eaau5758.
|
| [23] |
Bergers G，Fendt SM. The metabolism of cancer cells during metastasis［J］. Nat Rev Cancer，2021，21（3）：162-180.
|
| [24] |
Pan J，Dai Q，Zhang T，et al. Palmitate acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway［J］. Cancer Cell Int，2019，19：69.
|
| [25] |
Peck B，Schug ZT，Zhang Q，et al. Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments［J］. Cancer Metab，2016，4：6.
|
| [26] |
Peck B，Schulze A. Lipid desaturation - the next step in targeting lipogenesis in cancer？［J］. FEBS J，2016，283（15）：2767-2778.
|
| [27] |
Kikuchi K，Tsukamoto H. Stearoyl-CoA desaturase and tumorigenesis［J］. Chem Biol Interact，2020，316：108917.
|
| [28] |
Presler M，Wojtczyk-Miaskowska A，Schlichtholz B，et al. Increased expression of the gene encoding stearoyl-CoA desaturase 1 in human bladder cancer［J］. Mol Cell Biochem，2018，447（1-2）：217-224.
|
| [29] |
Luis G，Godfroid A，Nishiumi S，et al. Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1（SCD1）in cancer cells and Fatty Acid Biding Protein-4（FABP4）in tumor microenvironment promote tumor recurrence［J］. Redox Biol，2021，43：102006.
|
| [30] |
Wang C，Shi M，Ji J，et al. Stearoyl-CoA desaturase 1（SCD1）facilitates the growth and anti-ferroptosis of gastric cancer cells and predicts poor prognosis of gastric cancer［J］. Aging（Albany NY），2020，12（15）：15374-15391.
|
| [31] |
Petruzzelli M，Schweiger M，Schreiber R，et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia［J］. Cell Metabolism，2014，20（3）：433-447.
|
| [32] |
Cohen P，Levy JD，Zhang Y，et al. Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch［J］. Cell，2014，156（1-2）：304-316.
|
| [33] |
Peng WQ，Xiao G，Li BY，et al. l-Theanine Activates the Browning of White Adipose Tissue Through the AMPK/α-Ketoglutarate/Prdm16 Axis and Ameliorates Diet-Induced Obesity in Mice［J］. Diabetes，2021，70（7）：1458-1472.
|
| [34] |
Simopoulos AP. An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity［J］. Nutrients，2016，8（3）：128.
|
| [35] |
Briscoe CP，Tadayyon M，Andrews JL，et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids［J］. J Biol Chem，2003，278（13）：11303-11311.
|
| [36] |
Hirasawa A，Tsumaya K，Awaji T，et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120［J］. Nat Med，2005，11（1）：90-94.
|
| [37] |
Freitas RDS，Campos MM. Protective Effects of Omega-3 Fatty Acids in Cancer-Related Complications［J］. Nutrients，2019，11（5）：945.
|
| [38] |
Freitas RDS，Muradás TC，Dagnino APA，et al. Targeting FFA1 and FFA4 receptors in cancer-induced cachexia［J］. Am J Physiol Endocrinol Metab，2020，319（5）：E877-E892.
|
| [39] |
Hanai N，Terada H，Hirakawa H，et al. Prospective randomized investigation implementing immunonutritional therapy using a nutritional supplement with a high blend ratio of ω-3 fatty acids during the perioperative period for head and neck carcinomas［J］. Jpn J Clin Oncol，2018，48（4）：356-361.
|
| [40] |
Manson JE，Cook NR，Lee IM，et al. Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer［J］. N Engl J Med，2019，380（1）：23-32.
|
| [41] |
Bai D，Wu Y，Deol P，et al. Palmitic acid negatively regulates tumor suppressor PTEN through T366 phosphorylation and protein degradation［J］. Cancer Lett，2021，496：127-133.
|
| [42] |
Pascual G，Domínguez D，Elosúa-Bayes M，et al. Dietary palmitic acid promotes a prometastatic memory via Schwann cells［J］. Nature，2021，599（7885）：485-490.
|
| [43] |
Johns N，Stephens NA，Fearon KC. Muscle wasting in cancer［J］. Int J Biochem Cell Biol，2013，45（10）：2215-2229.
|
| [44] |
Kanarek N，Petrova B，Sabatini DM. Dietary modifications for enhanced cancer therapy［J］. Nature，2020，579（7800）：507-517.
|
| [45] |
Brandhorst S，Choi IY，Wei M，et al. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration，Enhanced Cognitive Performance，and Healthspan［J］. Cell Metabolism，2015，22（1）：86-99.
|
| [46] |
Gallagher EJ，LeRoith D. Minireview：IGF，Insulin，and Cancer［J］. Endocrinology，2011，152（7）：2546-2551.
|
| [47] |
Weber DD，Aminazdeh-Gohari S，Kofler B. Ketogenic diet in cancer therapy［J］. Aging（Albany NY），2018，10（2）：164-165.
|
| [48] |
Allen BG，Bhatia SK，Anderson CM，et al. Ketogenic diets as an adjuvant cancer therapy：History and potential mechanism［J］. Redox Biol，2014，2：963-970.
|
| [49] |
Torrence ME，Manning BD. Nutrient sensing in cancer［J］. Ann Rev Cancer Biol，2018，2：251-269.
|
| [50] |
Fruman DA，Chiu H，Hopkins BD，et al. The PI3K Pathway in Human Disease［J］. Cell，2017，170（4）：605-635.
|
| [51] |
Hopkins BD，Pauli C，Du X，et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors［J］. Nature，2018，560（7719）：499-503.
|
| [52] |
Hao JW，Wang J，Guo H，et al. CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis［J］. Nat Communication，2020，11（1）：4765.
|
| [53] |
Cao W，Yang W，Fan R，et al. miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway［J］. Tumour Biol，2014，35（2）：1287-1295.
|
| [54] |
俞发荣，李建军，Yu Xin，等. 不饱和脂肪酸对人胃癌细胞PI3K-Akt信号通路中相关基因表达的影响［J］.生态科学，2019，38（06）：60-63.
|
| [1] |
Bray F，Ferlay J，Soerjomataram I，et al. Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin，2018，68（6）：394-424.
|
| [2] |
Argilés JM，Stemmler B，López-Soriano FJ，et al. Inter-tissue communication in cancer cachexia［J］. Nat Rev Endocrinol，2018，15（1）：9-20.
|
| [3] |
Fearon K，Strasser F，Anker SD，et al. Definition and classification of cancer cachexia：an international consensus［J］. Lancet Oncol，2011，12（5）：489-495.
|
| [4] |
Porporato PE. Understanding cachexia as a cancer metabolism syndrome［J］. Oncogenesis，2016，5（2）：e200.
|
| [5] |
Maan M，Peters JM，Dutta M，et al. Lipid metabolism and lipophagy in cancer［J］. Biochem Biophys Res Commun，2018，504（3）：582-589.
|
| [6] |
Koundouros N，Poulogiannis G. Reprogramming of fatty acid metabolism in cancer［J］. Br J Cancer，2020，122（1）：4-22.
|
| [7] |
Ma Y，Temkin SM，Hawkridge AM，et al. Fatty acid oxidation：An emerging facet of metabolic transformation in cancer［J］. Cancer Lett，2018，435：92-100.
|
| [8] |
Wang Q，Li D，Cao G，et al. IL-27 signaling promotes adipocyte thermogenesis and energy expenditure［J］. Nature，2021，600（7888）：314-318.
|
| [9] |
Kir S，Spiegelman BM. CACHEXIA & BROWN FAT：A BURNING ISSUE IN CANCER［J］. Trends Cancer，2016，2（9）：461-463.
|
| [10] |
Kir S，White JP，Kleiner S，et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia［J］. Nature，2014，513（7516）：100-104.
|
| [11] |
Argilés JM. The 2015 ESPEN Sir David Cuthbertson lecture：Inflammation as the driving force of muscle wasting in cancer［J］. Clin Nutr，2017，36（3）：798-803.
|
| [12] |
Archid R，Solass W，Tempfer C，et al. Cachexia Anorexia Syndrome and Associated Metabolic Dysfunction in Peritoneal Metastasis［J］. Int J Mol Sci，2019，20（21）：5444.
|
| [13] |
Fukawa T，Yan-Jiang BC，Min-Wen JC，et al. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia［J］. Nat Med，2016，22（6）：666-671.
|
| [14] |
Lu S，Wang Y. Nonmetabolic functions of metabolic enzymes in cancer development［J］. Cancer Communication（London），2018，38（1）：63.
|
| [15] |
Fearon KC，Glass DJ，Guttridge DC. Cancer cachexia：mediators，signaling，and metabolic pathways［J］. Cell Metabolism，2012，16（2）：153-166.
|
| [16] |
Riuzzi F，Sorci G，Sagheddu R，et al. RAGE in the pathophysiology of skeletal muscle［J］. J Cachexia Sarcopenia Muscle，2018，9（7）：1213-1234.
|
| [17] |
Li Z，Zhang H. Reprogramming of glucose，fatty acid and amino acid metabolism for cancer progression［J］. Cell Mol Life Sci，2016，73（2）：377-392.
|
| [18] |
Hao JW，Wang J，Guo H，et al. CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis［J］. Nat Commun，2020，11（1）：4765.
|
| [19] |
Pascual G，Avgustinova A，Mejetta S，et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36［J］. Nature，2017，541（7635）：41-45.
|
| [20] |
Calvo D，Gómez-Coronado D，Suárez Y，et al. Human CD36 is a high affinity receptor for the native lipoproteins HDL，LDL，and VLDL［J］. J Lipid Res，1998，39（4）：777-788.
|